Pinkerneil, M., Hoffmann, M. J., Kohlhof, H., Schulz, W. A., & Niegisch, G. (2016). Evaluation of the Therapeutic Potential of the Novel Isotype Specific HDAC Inhibitor 4SC-202 in Urothelial Carcinoma Cell Lines. Target Oncol.

Pinkerneil, Maria, Michèle J. Hoffmann, Hella Kohlhof, Wolfgang A. Schulz, et Günter Niegisch. "Evaluation of the Therapeutic Potential of the Novel Isotype Specific HDAC Inhibitor 4SC-202 in Urothelial Carcinoma Cell Lines." Target Oncol 2016.

Pinkerneil, Maria, et al. "Evaluation of the Therapeutic Potential of the Novel Isotype Specific HDAC Inhibitor 4SC-202 in Urothelial Carcinoma Cell Lines." Target Oncol 2016.